Margie L. Traylor - 14 Jun 2023 Form 4 Insider Report for Augmedix, Inc.

Role: Director
Signature: /s/ Margie L. Traylor
Issuer symbol: N/A
Transactions as of: 14 Jun 2023
Net transactions value: +$119,649
Form type: 4
Filing time: 16 Jun 2023, 17:50:05 UTC
Previous filing: 17 May 2023
Next filing: 17 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUGX	Common Stock	Purchase	$119,649	+26,530	+128%	$4.51	47,331	14 Jun 2023	Direct	F1
transaction	AUGX	Common Stock	Options Exercise		+52,632	+111%		99,963	16 Jun 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Restricted Stock Units	Options Exercise	$0	+52,632		$0.000000^*	0	16 Jun 2023	Common Stock	52,632		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades ranging from $4.47 to $4.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F3	On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.